title: High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study.
authors.forename: Luana
authors.initials: L
authors.lastname: Fianchi
authors.forename: Marianna
authors.initials: M
authors.lastname: Criscuolo
authors.forename: Massimo
authors.initials: M
authors.lastname: Breccia
authors.forename: Luca
authors.initials: L
authors.lastname: Maurillo
authors.forename: Flavia
authors.initials: F
authors.lastname: Salvi
authors.forename: Pellegrino
authors.initials: P
authors.lastname: Musto
authors.forename: Giovanna
authors.initials: G
authors.lastname: Mansueto
authors.forename: Gianluca
authors.initials: G
authors.lastname: Gaidano
authors.forename: Carlo
authors.initials: C
authors.lastname: Finelli
authors.forename: Antonietta
authors.initials: A
authors.lastname: Aloe-Spiriti
authors.forename: Valeria
authors.initials: V
authors.lastname: Santini
authors.forename: Mariangelo
authors.initials: M
authors.lastname: Greco
authors.forename: Stefan
authors.initials: S
authors.lastname: Hohaus
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Leone
authors.forename: Maria Teresa
authors.initials: MT
authors.lastname: Voso
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D001374:Azacitidine / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007558:Italy; D015477:Leukemia, Myelomonocytic, Chronic / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012074:Remission Induction; D012189:Retrospective Studies; D016019:Survival Analysis; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine